NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
26/04/2024
Voltar para busca
Dado oficial do USPTO
AMERSHAM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
AMERSHAM
ST13
US500000076410122Classe
1, 5, 9, 10, 42, 44
Pedido
76410122
Registro
2807878
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
26/04/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10, 42, 44
Data de depósito
20/05/2002
Data de registro
27/01/2004
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/04/2024
Última transação
26/04/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
1
Tipo de titular
99
Localização do titular
Buckinghamshire, GB
Examinador
BELL, MARLENE
Unidade examinadora
L50
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
GLOBAL LIFE SCIENCES SOLUTIONS OPERATIONS UK LTD
GE HEALTHCARE LIMITED
AMERSHAM PLC
Representantes
Dyan M. House Baker & Mckenzie, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalsbiochemicals and reagents for use in industryscience and researchnucleotidesfluorescent nucleotidesoligonucleotidespeptidesproteinsamino acidsorganic moleculesmarkers for DNA/RNA synthesis; reagents for luminescence; reagents for gene expression quantification; reagents for use with the polymerase chain reactionPCRprocess and the rolling circle amplification (RCA) process; reagents for cDNA cloning vectorsmodifying and restriction enzymes; reagents for labelingdetecting sequencing and fragment analysis of nucleic acidsproteinscustom synthesis; reagents for recombinant protein expression purificationchromatography media; electrophoresis; spectrophotometry and fluorometry; radiochemicals; scintillation assays; and high through put screening assays for drug development; and chemical preparations and substances for use in the manufacture of pharmaceutical products; diagnostic preparations and substances; chemical test reagentssaline solution and reagent-coated paperall for scientific and laboratory use; fissionable chemical elements; radioactive elements and isotopes for industrialscientificresearch purposes; radioactive sources and standards for use in radiographic techniques; radioactive sources for use in non-destructive testingpurification or sterilizing techniques for use in industryscience and research; chemical preparationskits and reagents for analysis or diagnosis used for scientific purposescell separation and culture; nucleic acid purification ; and radionuclidesgases and gas mixtures for industrialscientificresearch purposes
Classe 5
Diagnostic agentspreparations and substances for medical purposes; Contrast media for medical imaging; diagnostic scanning agents for in vivo use; radiopharmaceutical products for clinicalmedical and research use; radioactive sources and standards for use in nuclear medicine; radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use; pharmaceutical preparations for use in diagnosis; pre-filled vials and cartridges containing medical diagnostic reagents or saline solution; and radioisotope brachytherapy substances
Classe 9
Scientific apparatus and instruments used for radiology for the purpose of measuringmonitoring and surveying; computersprinterssoftware programs used for the purpose of life science research and for nuclear cardiology and medical imagingfor use by laboratoriespharmaciesdoctorshospitalsmedical service providers; radiology apparatus and instruments for the reading and interpretation of autoradiographs and filmsautomated film readers and scanners; apparatus for electrophoresis; chromatography columns and pumps; apparatus for microfabrication; apparatus for scintillation; imaging apparatus for radioactive and luminescent emissions; synthesis and purification integrated systems for use in radiology; apparatus for manufacturing oligonucleotides; apparatus for microarrays; microarray slides; laboratory glassware; laboratory vials and microvials; microtitre plates; and parts and fittings for the aforesaid goods
Classe 10
Surgicalmedicaldentalveterinary apparatus and instruments used for the purpose of measuringmonitoring and surveying in the field of radiotherapycomprised of medical needlessuture needlesimplantable radiation therapy devices and implantable radiation therapy devices consisting of encapsulated radioisotope brachytherapy sourcesradiation therapy delivery system consisting primarily of radioactive seeds and a bio-absorbable carrier assembly; magnetic resonance imagersMRI; x-ray apparatus for medical use; x-ray diagnostic apparatuscomputerized tomographyCAT scanners and ultrasound imagers; radiological apparatus for diagnostic and medical purposes; diagnostic and test kits for clinical medical use comprised of test tubestest plates and indicator charts for evaluating test results; vials; cannulas; needles and syringes; injectors; cartridges; infusion pumps for intravenous administration of fluids; needles for medical purposes; and parts and fittings for the aforesaid goods
Classe 42
Advisory services for pharmaceutical companies in the field of purification and chromatography; research and development services in the field of pharmaceutical and life sciences; research and product development for othersresearch and development of pharmaceuticalmedicalveterinary preparationsdiagnostic media and agents for use in medical and diagnostic imaging; consultancy services relating to chemical and pharmaceutical research; analytical services in the fields of medicinepharmaceuticals and biochemistry; radiolableling servicesisotopic labeling of biological molecules; pharmaceutical drug development services for pharmaceutical companies and medical professionals
Classe 44
Medical diagnostic services; medical imaging services; providing medical and medical product information to pharmaceutical companies and medical professionals
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
26/04/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
26/04/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
26/04/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
28/12/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
22/09/2023
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
22/09/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/09/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/09/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
22/09/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
22/09/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
27/01/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/10/2020
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
28/07/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
28/07/2014
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
28/07/2014
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
28/07/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
24/07/2014
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/02/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/02/2010
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
02/02/2010
E815
TEAS SECTION 8 & 15 RECEIVED
02/02/2010
CFIT
CASE FILE IN TICRS
07/06/2007
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/02/2005
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/02/2005
R.PR
REGISTERED-PRINCIPAL REGISTER
27/01/2004
PUBO
PUBLISHED FOR OPPOSITION
04/11/2003
NPUB
NOTICE OF PUBLICATION
15/10/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/06/2003
CNEA
EXAMINERS AMENDMENT MAILED
24/06/2003
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
16/06/2003
1.BD
Sec. 1(B) CLAIM DELETED
21/03/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/03/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/01/2003
PAPER RECEIVED
28/01/2003
CNRT
NON-FINAL ACTION MAILED
06/12/2002
CNEA
EXAMINERS AMENDMENT MAILED
27/11/2002
CNRT
NON-FINAL ACTION MAILED
27/08/2002
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AMERSHAM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.